Impact Healthcare REIT (LON:IHR) Receives Buy Rating from Jefferies Financial Group

Impact Healthcare REIT (LON:IHRGet Free Report)‘s stock had its “buy” rating restated by equities researchers at Jefferies Financial Group in a research report issued on Tuesday, MarketBeat reports. They presently have a GBX 114 ($1.44) price target on the stock. Jefferies Financial Group’s target price indicates a potential upside of 34.12% from the stock’s previous close.

Impact Healthcare REIT Price Performance

Shares of IHR opened at GBX 85 ($1.08) on Tuesday. The company has a current ratio of 2.54, a quick ratio of 2.37 and a debt-to-equity ratio of 39.36. Impact Healthcare REIT has a 1 year low of GBX 77.10 ($0.98) and a 1 year high of GBX 96.90 ($1.23). The stock has a market cap of £352.21 million, a P/E ratio of 2,125.00, a price-to-earnings-growth ratio of 1.95 and a beta of 0.33. The stock’s 50-day moving average price is GBX 86.28 and its two-hundred day moving average price is GBX 85.26.

Insider Activity

In other Impact Healthcare REIT news, insider Cedi Frederick acquired 11,748 shares of the business’s stock in a transaction dated Monday, April 29th. The shares were acquired at an average price of GBX 85 ($1.08) per share, for a total transaction of £9,985.80 ($12,630.66). 8.00% of the stock is currently owned by company insiders.

Impact Healthcare REIT Company Profile

(Get Free Report)

Impact Healthcare REIT plc is a specialist and responsible owner of care homes and other healthcare properties across the UK. Elderly care is an essential service and demand for it is high and continues to grow as the UK's population gets older. We work with our tenants so we can grow together and help them care for more people, while continuing to improve our homes for their residents.

Recommended Stories

Receive News & Ratings for Impact Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Impact Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.